BENZOTRIAZOLE DERIVATIVES AND REAGENTS CONTAINING SAME FOR ANALYZING CARBOXYLIC ACIDS

Abstract: The invention provides compounds represented by formula (I) and their salts, wherein R¹ represents C₁-C₅ alkylene, R² and R³, which may be the same or different, each represents hydrogen, C₁-C₅ alkyl, C₁-C₅ alkyloxy, amino, mono- or di(C₁-C₅ alkyl) amino (provided that R² and R³ do not represent hydrogen at the same time) or, when taken together, epresent C₁-C₅ alkylenedioxy, and R⁴ represents hydrogen or C₁-C₅ alkyl. Since the compounds react with a carboxylic acid in a short time at room temperature in the presence of a condensing agent to produce amides emitting strong fluorescence,thus being useful as reagents for determining carboxylic acids rapidly with high sensitivity.

Description: Carboxylic acids exist widely in the living body as the metabolites of carbohydrates, lipides, and proteins, and each acid plays an important role. This invention relates to the compounds suitable for microanalysis of these carboxylic acids and to fluorescence labeling reagents thereof. Fig 1 illustrates the relationship between the concentration of flufenamic acid and the peak area of the chromatogram, where the ordinate shows the peak area (× 10⁴) and the abscissa the concentration of flufenamic acid (ng/500µl). Fig 2 is the chromatogram obtained in Experiment 1, where the abscissa shows retention time (minutes) and the peak indicated by the arrow corresponds to flufenamic acid (about 0.2ng). Fig 3 illustrates the relationship between the concentration of ibuprofen and the peak area (× 10⁶) of the chromatogram, where the ordinate shows the peak area (× 10⁶) and the abscissa the concentration of ibuprofen, (ng/500µl). Fig 4 is the chromatogram obtained in Experiment 2, where the abscissa shows retention time (minutes) and the peak indicated by the arrow corresponds to ibuprofen (about 0.02ng). Recently, attention has been paid to prostaglandins with a wide variety of physiological activities, bile acids metabolized from cholesterol and oxy acids, keto acids, etc which are thought to be important for the diagnosis or the treatment of congenital dysbolism. It is hoped to develop a simple, rapid, and high sensitive method for their quantitative detection. Nimura et al disclose 9-anthryldiazomethane (N. Nimura, T. Kinoshita: Anal. Lett., 13 , 191 〈1980〉). 9-anthryldiazomethane is advantageous in its reactivity with carboxylic acids at room temperature, but often causes problems in the course of detection because of its unstability. Tsuchiya et al disclose the method for fluorescence detection of 7-hydroxy-4-hydroxymethylcoumarin, prepared by labeling carboxylic acids with 7-acetoxy-4-bromomethylcoumarin (ABMC), separating the same by reversed phase HPLC followed by alkaline hydrolysis (H. Tsuchiya et al: J. Chromatogr., 234 , 121 (1982)). This method has the merit that the detection limit is high (several ten fmol) without the influence of the solvent in the mobile phase, but some demerits in that it needs complicated procedures such as heating in the case of the reaction of carboxylic acids with ABMC, and alkaline hydrolysis after separation. It is therefore the object of the present invention to develop labeling reagents which are reactive under mild conditions and are highly sensitive but do not disturb the detection. The solution are the compounds of the present invention with the following formula: wherein R¹ means C₁-C₅ alkylene; R² and R³ each are identically or differently hydrogen, C₁-C₅ alkyl, C₁-C₅ alkyloxy, amino, or mono- or di-C₁-C₅ alkylamino, provided that R² and R³ are not both hydrogen at the same time, or form together C₁-C₅ alkylendioxy; and R⁴ means hydrogen or C₁-C₅ alkyl, or a salt thereof (hereafter referred to simply as the compounds of this invention) which react with carboxylic acids quickly at room temperature in the presence of a condensing reagent. The reactants are amides having strong fluorescence and excessive reagents can be eliminated easily. Thus, the compounds of this invention make the detection of carboxylic acids, simple, rapid and very sensitive. Therefore they are useful. The compounds of this invention react with carboxylic acids in an aprotic solvent in the presence of a condensing reagent and a base or an acid-scavenger in place of the base, within about 30 minutes at room temperature, thereby corresponding amides showing strong fluorescence are formed. Besides, excessive reagents can be removed easily from the reaction mixture by passing the reaction solution through a silicagel column for pretreatment. The compounds of this invention react with a wide variety of carboxylic acids, regardless whether they are aromatic or aliphatic ones. It is desirable that R² and R³ have higher electron-donating property, since such property gives high fluorescence intensity to the resulting compound. The compounds of this invention can be prepared easily by reactions known in the field of organic chemistry. For example, as shown below, a substituted aniline (a) is subjected to the known diazo coupling reaction with diazo compound (b) having an aminoalkyl group protected by a suitable protective group (Step 1), then to an oxidative ring-closing reaction (Step 2), followed by deprotection (Step 3), to give the compound ( I ) of this invention. In the reaction scheme, R¹, R², R³, and R⁴ each have the same meaning as defined above, R⁵ means a protective group. The process above is explained below step by step. (Step 1) The reaction is usually carried out in an aqueous solution at a temperature from ice-cooling to 15°C. An aniline derivative corresponding to the diazo compound (b) is dissolved or suspended in an inorganic acid, which is then reacted with nitrous acid added as sodium nitrite to obtain the highly reactive diazo compound (b). Sulfamic acid or urea is added thereto to remove excessive nitrous acid. Next, the substituted aniline compound (a) is added thereto, whereby it is easily coupled with the diazo compound (b) to give the compound (c). The reaction is completed in several minutes to several hours. (Step 2) The azo group of the compound (c) easily forms an oxidative ring closure with the adjacent amine to give the triazole compound (d). The reaction is completed in several minutes to several ten hours at room temperature or under heating, if carried out in a water-containing organic solvent in the presence of a copper-ammonia complex. (Step 3) The compound (d) is subjected to hydrolysis in a water-containing organic solvent in the presence of an acid or a base to give the compound ( I ) of this invention. The reaction is completed in several minutes to several days at room temperature or under heating. In the invention, C₁-C₅ alkylene means a straight chain C₁-C₅ alkylene including methylene, ethylene, propylene, butylene, and pentylene, especially methylene or ethylene is preferable. C₁-C₅ alkyl means a straight or branched chain C₁-C₅ alkyl, including methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, tert-butyl, n-pentyl, isopentyl, neopentyl, and tert-pentyl. As for the protecting group, all the known protecting groups for amine can be used. Among others, those stable for acids are preferable, for example, acetyl, trifluoroacetyl, and benzoyl. The representative examples of the compounds of this invention are listed below, which do not limit the scope of the invention. (1) 2-(p-aminomethylphenyl)-N,N-dimethyl-2H-benzotriazolyl-5-amine, (2) 2-[p-(2-aminoethyl)phenyl)-N,N-dimethyl-2H-benzotriazolyl-5-amine dihydrochloride, (3) 2-(p-aminomethylphenyl)-2H-benzotriazolyl-5-amine, (4) p-(5,6-dimethoxy-2H-benzotriazol-2-yl)benzylamine, (5) p-(5,6-methylenedioxy-2H-benzotriazol-2-yl)phenethylamine, (6) 4-[m-(5-propoxy-2H-benzotriazol-2-yl)phenyl]butylamine, (7) 4-butoxy-2-[m-(3-methylaminopropyl)phenyl]-2H-benzotriazolyl-5-amine, (8) N-butyl-5-[o-(5-ethoxy-7-butyl-2H-benzotriazol-2-yl)phenyl]pentylamine, (9) N-isopropyl-m-(5,6-ethylenedioxy-2H-benzotriazol-2-yl) phenethylamine, and (10)2-(o-aminomethylphenyl)-N,N-dimethyl-2H-benzotriazolylene-5, 6-diamine. This invention is further explained in the following Examples and Experiments, which are not intended to limit the scope of this invention. Example The compounds 1-5 of this invention were prepared as shown in the following Examples 1-5. Physical constants on each compound are shown on table 1. Example 1 Preparation of 2-(p-aminomethylphenyl)-N,N-dimethyl-2H-benzotriazolyl-5-amine (1) To a solution of N-(p-aminobenzyl)acetamide (6.6g) dissolved in 100ml of 10% hydrochloric acid was added 10% sodium nitrite (30ml), while being stirred under ice-cooling. Fifteen minutes later, 10% ammonium sulfamate (50ml) was added thereto, and the mixture was stirred for 15 minutes. The reaction mixture was adjusted to about pH 5 with sodium acetate, added with N,N-dimethyl-m-phenylenediamine dihydrochloride (8.4g), and the resulting mixture was stirred for 4 hours. The reaction mixture was adjusted to about pH 9 with 1N sodium hydroxide, filtered to collect precipitates, which were then washed well with water. They were recrystallized from dimethylformamide/methanol to give the pure azo compound as red plates, m.p. 138-139°C. To a solution of the resultig azo compound (8.7g) dissolved in pyridine (100ml) was added an ammoniacal cupric sulfate solution which was prepared by dissolving cupric sulfate pentahydrate in 150ml of 14% aqueous ammonia, then the mixture was refluxed for 4 hours. After completion of the reaction, the mixture was cooled and extracted with ethyl acetate. The ethyl acetate layer was dried over anhydrous sodium sulfate and evaporated to leave a residue, which was recrystallized from aqueous ethanol to give the objective compound (1) as acetate, yellow needles, m.p. 196-197°C. To a solution of the acetate (7g) dissolved in ethanol (200ml) was added 10% hydrochloric acid (50ml), then the mixture was refluxed for 5 days. After completion of the reaction, the reaction mixture was concentrated to about 50ml (total volume), and filtered. The filtrate was neutralized with sodium bicarbonate to leave precipitates, which were collected by filtration, washed well with water, and recrystallized from methanol to give the objective compound (1). Example 2 Preparation of 2-(p-(2-aminoethyl)phenyl]-N,N-dimethyl-2H-benzotriazolyl-5-amine dihydrochloride (2) The reaction was performed according to the same manner as in Example 1 except that N-(p-aminophenethyl)-2,2,2-trifluoroacetamide hydrochloride (8.1g) was used in place of N-(p-aminobenzyl)acetamide. The extract which resulted from an oxidative ring closure reaction with an ammoniacal cupric sulfate solution was dissolved, without recrystallization, in ethanol (50ml), combined with 5N aqueous solution of sodium hydroxide (20ml), and the mixture refluxed for 2 hours. After completion of the reaction, the mixture was combined with water (100ml) and extracted with ethyl acetate. The ethyl acetate layer was evaporated under reduced pressure and the oily residue was dissolved in ethyl ether (20ml). After filtration, the filtrate was added to an ethanolic solution of hydrochloric acid to give the objective compound (2). Example 3 Preparation of 2-(p-aminomethylphenyl)-2H-benzotriazolyl-5-amine (3) The reaction was performed according to the same manner as in Example 1, except that m-phenylenediamine dihydrochloride (7.2g) was used in place of N,N-dimethyl-m-phenylenediamine dihydrochloride, to give the objective compound (3). Example 4 Preparation of p-(5,6-dimethoxy-2H-benzotriazol-2-yl) benzylamine (4) The reaction was performed according to the same manner as in Example 1, except that 3,4-dimethoxyaniline (6.4g) was used in place of N,N-dimethyl-m-phenylenediamine dihydrochloride, to give the objective compound (4). Example 5 Preparation of p-(5,6-methylenedioxy-2H-benzotriazol-2-yl)phenethylamine (5) The reaction was performed according to the same manner as in Example 2, except that 3,4-methylenedioxyaniline (5.6g) was used in place of N,N-dimethyl-m-phenylenediamine dihydrochloride. After the completion of hydrolysis, the reaction mixture was extracted with ethyl acetate, and the organic layer was evaporated under reduced pressure to leave a residue, which was recrystallized from methanol to give the objective compound (5). No Appearance IR (Nujol) m.p.(°C) Molecular Formula Elementary Analysis (Calcd./Found) C H N 1 yellow needles 3300, 3380 127-128 C₁₅H₁₇N₅ 67.39 6.41 26.20 67.45 6.37 26.15 2 light red plates 2450, 2550 250-260 C₁₆H₂₁N₅Cl₂ 54.24 5.97 19.77 53.58 5.96 19.52 3 yellow plates 3150, 3300, 3350, 3430 206-207 C₁₃H₁₃N₅ 65.25 5.48 29.27 65.27 5.51 29.18 4 colorless needles 3300, 3350, 3480 155-156 C₁₅H₁₆N₄O₂·½H₂O 61.42 5.84 19.10 61.54 5.83 19.05 5 colorless needles 1713, 3230, 145-147 C₁₅H₁₄N₄O₂·¼H₂O 62.82 5.10 19.54 62.66 5.21 19.55 Experiment (General Procedures for Analysis) In a 10ml vial, 0.5ml of an acetonitrile solution of a carboxylic acid compound is placed and acetonitrile solutions of 2-bromo-1-ethylpyridinium tetrafluoroborate (3.7mM), 9-methyl-3, 4-dihydro-2H-pyrido[1,2-a]pyrimidin-2-one (2.7mM), and the compound of this invention (3.7mM), are added thereto by 50µl each and the mixture stirred for about 10 seconds. This solution is allowed to stand at room temperature for about 30 minutes. This solution (0.5ml) is passed through a silicagel column for the pretreatment, with acetonitrile (1.5ml) as an eluent. Acetonitrile is added to the eluent to make the whole 2.5ml, 20 µl of which is subjected to HPLC. Excitation wavelength and fluorescence wavelength on each reagent in acetonitrile are shown in Table 2. Experiment 1 (The compound 1 of this invention as reagent) Acetonitrile solutions (0.5ml each) containing 3, 6, 15, 30, or 60ng of flufenamic acid were placed into 10ml vials. To each vial were added acetonitrile solutions (50µl each) of 2-bromo-1-ethylpyridinium tetrafluoroborate (3.7mM), 9-methyl-3, 4-dihydro-2H-pyrido[1,2-a]pyrimidin-2-one (2.7mM), and the compound of this invention (3.7mM), and the mixture were stirred for about 10 seconds. These were allowed to stand at room temperature for about 30 minutes. Each of these solutions (0.5ml) was passed through a Bond Elut column (silicagel) and eluted with acetonitrile (1.5ml). The total amount of the eluate was made 2.5ml with acetonitrile, the resulting solution (20µl) was subjected to HPLC. [Conditions for Measurement] Apparatus: Shimadzu LC-4A Pump (Shimadzu) Shimadzu RF-535 Fluorescence HPLC Monitor (same as above) Column: Novapack C₁₈(3.9×150mm; Waters) Guard Column: Nucleosil 5C₁₈(4.0×30mm; Nagel) Mobile Phase: acetonitrile/water = 2/1 Flow Rate: 1.2ml/minute Wavelength: 395nm for excitation, 510nm for fluorescence emission [Results] The relationship between the concentration of flufenamic acid and the peak area of the chromatogram as obtained in the experiment above is shown in Figure 1. The chromatogram is shown in Figure 2. Experiment 2 (The compound 5 of this invention as reagent) The experiment was performed in the same way as Example 1, except that the compound 5 of this invention was used as a reagent to acetonitrile solutions (0.5ml each) containing 0.6, 3, 6, 15, 30, or 60ng of ibuprofen. [Conditions for Measurement] Apparatus: same as Example 1 Column : Nucleosil 5C₁₈(4.6×150mm; Nagel) Guard Column: same as Example 1 Mobile Phase: acetonitrile/water = 5/3 Flow Rate: 1.0ml/minute Wavelength: 333nm for excitation, 375nm for fluorescence emission [Results] The relationship between the concentration of ibuprofen and the peak area of the chromatogram as obtained in the experiment above is shown in Figure 3. The chromatogram is shown in Figure 4. Experiment 3 Table 2 shows both excitation and fluorescence wavelength of amide compounds in acetonitrile, which are the reactants of the compounds (1)-(5) of this invention with benzoic acid. The date of detection limit for each amide compound by HPLC is also shown. No Excitation Wavelength(nm) Fluorescence Wavelength(nm) Detection Limit(fmol) 1 390 488 15 2 384 486 15 3 366 456 6 4 333 370 0.5 5 333 372 0.5

Claims: A compound of the following formula: wherein R¹ means C₁-C₅ alkylene; R² and R³ each is identically or differently hydrogen, C₁-C₅ alkyl, C₁-C₅ alkyloxy, amino, or mono- or di-C₁-C₅ alkylamino, provided that R² and R³ are not both hydrogen at the same time, or taken together may form C₁-C₅ alkylenedioxy; and R⁴ means hydrogen or C₁-C₅ alkyl, or the salt thereof. A reagent for determining carboxylic acids, comprising a compound of the following formula: wherein R¹ means C₁-C₅ alkylene; R² and R³ each is identically or differently hydrogen, C₁-C₅ alkyl, C₁-C₅ alkyloxy, amino, or mono- or di-C₁-C₅ alkylamino, provided that R² and R³ are not both hydrogen at the same time, or taken together may form C₁-C₅ alkylenedioxy; and R⁴ means hydrogen or C₁-C₅ alkyl, or the salt thereof.

Inventors: KITAGAWA TAKAYASU, NARITA SHIGERU, KITAGAWA, TAKAYASU, NARITA, SHIGERU
Applicants: SHIONOGI & CO, SHIONOGI & CO., LTD.
Application year: 1989
Main classification: C07D249
IPC codes: G01N31, C07D491, G01N33, C07D249